Inflammatory bowel disease Flashcards

1
Q

When does people typically develop IBD ?

A

before the age of 30.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the pathophysiology of Crohn’s Disease?

A

Inappropriate immune response against the
gut flora causes Transmural chronic inflammation anywhere in GI tract with rectal sparing. The worse affection is seen at the terminal ilium. The lesion distribution is called skipped lesions as there are unaffected segments between affected. The disease has genetic etiology, but is not fully elucidated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the epidemiology of Crohn’s Disease?

A

6 / 100,000 cases in Ireland with biomodal distribution one 15 – 35yoa and another 50 – 70yoa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the GI manifestations of Crohn’s disease ?

A
  • Crampy abdominal pain and Watery diarrhoea.
  • Bloody diarrhoea may or may not be present.
  • Evidence of malabsorption such as B12 deficiency and Steathorroea.
    *Aphthous ulcers, Odynophagia and Dysphagia.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the Extraintestinal Manifestations of Crohn’s disease ?

A

– Arthritis
– Uveitis and Episcleritis
– Pyoderma gangrenous
– Erythema nodosum
– Kidney stones
– Gallstones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the complications of Crohn’s disease ?

A
  • Intestinal Strictures and fistulas
  • Phlegmon which is the acute spreading soft tissue inflammation.
  • Perianal abscesses
  • Fissures
  • Increased risk for colorectal cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the utility of Calprotectin testing ?

A

It is a faecal protein marker of intestinal inflammation with low sensitivity and high specificity. It is Generally used to eliminate the likelihood of IBD in a patient presenting with chronic abdominal pain and diarrhoea. A positive test requires endoscopic follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should be the approach to negative Calprotectin testing ?

A

If faecal calprotectin is “negative” in a patient
with low risk for IBD, Consider workup and treatment for IBS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the colonoscopy or endoscopic features of Crohn’s disease ?

A

– Skip lesions
– “Cobblestoning”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the CT findings in Crohn’s disease ?

A

“Fat wrapping” or “Creeping fat sign” .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the biopsy findings in Crohn’s disease ?

A

– Transmural involvement
– Non-caseating granuloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Crohn’s disease sign in on barium enema?

A

String sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the algorithm for Crohn’s disease dx ?

A

https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2018/1201/p661-f1.jpg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the four major classes of drugs used in Crohn’s disease ?

A

1.Oral 5-aminosalicylates (eg, sulfasalazine, mesalamine)
2.Glucocorticoids (eg, prednisone, budesonide)
3.Immunomodulators (eg, azathioprine, 6-mercaptopurine, methotrexate)
4.Biologic therapies (eg, infliximab, adalimumab, certolizumab pegol, natalizumab, vedolizumab,
ustekinumab)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Step-up medical therapy approach in Crohn’s disease ?

A
  • Typically starts with less potent medications associated with fewer side effects
  • More potent & potentially more toxic meds are used only if initial therapies ineffective.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the top-down medical therapy approach in Crohn’s disease ?

A
  • Starts with more potent therapies, such as biologic therapy and/or immunomodulators
  • Done early in the course of the disease before patients become glucocorticoid dependent, and
    possibly even before they receive glucocorticoids
17
Q

What are the indications for surgery in Crohn’s disease ?

A

– Bowel perforation and abscess
– Gastrointestinal bleeding
– Symptomatic fibrotic stricture causing intestinal
obstruction or Enteric fistula
– Small bowel or colorectal cancer
– Refractory to medical therapy.
– Growth retardation in children with Crohn’s disease

18
Q

What is the pathophysiology of UC ?

A

Inappropriate immune response against the gut flor causing mucosal inflammation. The disease typically starts in rectum and spreads proximally through colon but NOT proximal to ileocecal valve. Smoking has a protective effect in UC as it is more common in non-smoker’s.

19
Q

What is the epidemiology of UC in Ireland ?

A

15/100,000 cases with bimodal distribution 15 to 35 years and 50 to 70 years.

20
Q

What are the intestinal manifestation of UC ?

A

– Abdominal pain
– Diarrhoea Episodic or chronic and can be Bloody non-bloody.
– Tenesmus

21
Q

What are the systemic symptoms during acute flare of UC ?

A

– Fever
– Malaise
– Anorexia

22
Q

What are the extra colonic manifestations of UC ?

A

– Iron deficiency anaemia
– Arthritis
– Uveitis or Episcleritis
– Primary Sclerosing Cholangitis
– Pyoderma gangrenosum
– Erythema nodosum

23
Q

What is the presentation of severe UC ?

A
  • Severe GI bleeding
  • Colitis
    – Continuous bleeding and > 10 stools per day
  • Toxic megacolon
  • Increased risk for colorectal cancer
24
Q

What is the diagnostic criteria for UC ?

A
  1. Chronic diarrhoea x 4 weeks
  2. Colonoscopy
    – Circumferential inflammation and Ulceration
    – Friable mucosa that bleeds during biopsy
  3. Biopsy
    – Mucosa AND submucosa involvement
    – Crypt abscesses
25
Q

What is the remission induction therapy for Proctitis or proctosigmoiditis?

A

*Topical mesalamine (suppository or enema); if needed, one of the following may be added:
– Topical or oral glucocorticoid
– Oral 5-ASA

26
Q

What is the remission induction therapy for extensive UC ?

A

Topical mesalamine + oral 5-ASA; if unsuccessful,
Oral 5-ASA + topical glucocorticoid

27
Q

When is maintenance therapy required in UC ?

A
  • Provided to every patient with UC unless disease limited to ulcerative proctitis with ≤ 1 flare per year.
  • Choice of maintenance therapy depends on which drug induced remission.
    *General recommendation is to continue that drug at lowest possible dose.
28
Q

What is the pathophysiology of toxic megalocolon in UC ?

A

Inflammation increases NO synthesis by macrophages and smooth muscle cells leading to dilation of the colon and colonic muscular paralysis.

29
Q

What is the clinical presentation of toxic megalocolon ?

A

It occurs early after diagnosis with repeated episodes in the first few years. Patients presents with severe bloody diarrhoea, abdominal pain and distention. They may often have malase, tachicardia, alterd mental status, fever and hypotension.

30
Q

What is the diagnostic criteria for toxic megalocolon ?

A
  • Radiographic evidence of colonic
    dilation (diameter > 6 cm) .
  • PLUS at least three of the following: Fever >38ºC, Heart rate >120 beats/min, Neutrophilic leucocytosis > 10,500/microL, and Anaemia.
  • PLUS at least one of the following: Dehydration, Altered sensorium, Electrolyte disturbance and Hypotension
31
Q

What is the treatment of toxic megalocolon ?

A

– ICU admission
– Bowel rest followed by enteral
feeding and Antibiotics
– Stop all meds that can impede
colonic motility (e.g., opiates)
– Intermittent rolling or knee-elbow position to expel gas